The PRMT5/WDR77 complex restricts hepatitis E virus replication.

Hepatitis E virus (HEV) is one of the main pathogenic agents of acute hepatitis in the world. The mechanism of HEV replication, especially host factors governing HEV replication is still not clear. Here, using HEV ORF1 trans-complementation cell culture system and HEV replicon system, combining with...

Full description

Bibliographic Details
Main Authors: Xiaohui Ju, Yanying Yu, Wenlin Ren, Lin Dong, Xianbin Meng, Haiteng Deng, Yuchen Nan, Qiang Ding
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-06-01
Series:PLoS Pathogens
Online Access:https://doi.org/10.1371/journal.ppat.1011434
_version_ 1797688361324904448
author Xiaohui Ju
Yanying Yu
Wenlin Ren
Lin Dong
Xianbin Meng
Haiteng Deng
Yuchen Nan
Qiang Ding
author_facet Xiaohui Ju
Yanying Yu
Wenlin Ren
Lin Dong
Xianbin Meng
Haiteng Deng
Yuchen Nan
Qiang Ding
author_sort Xiaohui Ju
collection DOAJ
description Hepatitis E virus (HEV) is one of the main pathogenic agents of acute hepatitis in the world. The mechanism of HEV replication, especially host factors governing HEV replication is still not clear. Here, using HEV ORF1 trans-complementation cell culture system and HEV replicon system, combining with stable isotope labelling with amino acids in cell culture (SILAC) and mass spectrometry (MS), we aimed to identify the host factors regulating HEV replication. We identified a diversity of host factors associated with HEV ORF1 protein, which were putatively responsible for viral genomic RNA replication, in these two cell culture models. Of note, the protein arginine methyltransferase 5 (PRMT5)/WDR77 complex was identified in both cell culture models as the top hit. Furthermore, we demonstrated that PRMT5 and WDR77 can specifically inhibit HEV replication, but not other viruses such as HCV or SARS-CoV-2, and this inhibition is conserved among different HEV strains and genotypes. Mechanistically, PRMT5/WDR77 can catalyse methylation of ORF1 on its R458, impairing its replicase activity, and virus bearing R458K mutation in ORF1 relieves the restriction of PRMT5/WDR77 accordingly. Taken together, our study promotes more comprehensive understanding of viral infections but also provides therapeutic targets for intervention.
first_indexed 2024-03-12T01:30:06Z
format Article
id doaj.art-49f91b1ab2194daeaa5135c61bd4225b
institution Directory Open Access Journal
issn 1553-7366
1553-7374
language English
last_indexed 2024-03-12T01:30:06Z
publishDate 2023-06-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Pathogens
spelling doaj.art-49f91b1ab2194daeaa5135c61bd4225b2023-09-12T05:31:31ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742023-06-01196e101143410.1371/journal.ppat.1011434The PRMT5/WDR77 complex restricts hepatitis E virus replication.Xiaohui JuYanying YuWenlin RenLin DongXianbin MengHaiteng DengYuchen NanQiang DingHepatitis E virus (HEV) is one of the main pathogenic agents of acute hepatitis in the world. The mechanism of HEV replication, especially host factors governing HEV replication is still not clear. Here, using HEV ORF1 trans-complementation cell culture system and HEV replicon system, combining with stable isotope labelling with amino acids in cell culture (SILAC) and mass spectrometry (MS), we aimed to identify the host factors regulating HEV replication. We identified a diversity of host factors associated with HEV ORF1 protein, which were putatively responsible for viral genomic RNA replication, in these two cell culture models. Of note, the protein arginine methyltransferase 5 (PRMT5)/WDR77 complex was identified in both cell culture models as the top hit. Furthermore, we demonstrated that PRMT5 and WDR77 can specifically inhibit HEV replication, but not other viruses such as HCV or SARS-CoV-2, and this inhibition is conserved among different HEV strains and genotypes. Mechanistically, PRMT5/WDR77 can catalyse methylation of ORF1 on its R458, impairing its replicase activity, and virus bearing R458K mutation in ORF1 relieves the restriction of PRMT5/WDR77 accordingly. Taken together, our study promotes more comprehensive understanding of viral infections but also provides therapeutic targets for intervention.https://doi.org/10.1371/journal.ppat.1011434
spellingShingle Xiaohui Ju
Yanying Yu
Wenlin Ren
Lin Dong
Xianbin Meng
Haiteng Deng
Yuchen Nan
Qiang Ding
The PRMT5/WDR77 complex restricts hepatitis E virus replication.
PLoS Pathogens
title The PRMT5/WDR77 complex restricts hepatitis E virus replication.
title_full The PRMT5/WDR77 complex restricts hepatitis E virus replication.
title_fullStr The PRMT5/WDR77 complex restricts hepatitis E virus replication.
title_full_unstemmed The PRMT5/WDR77 complex restricts hepatitis E virus replication.
title_short The PRMT5/WDR77 complex restricts hepatitis E virus replication.
title_sort prmt5 wdr77 complex restricts hepatitis e virus replication
url https://doi.org/10.1371/journal.ppat.1011434
work_keys_str_mv AT xiaohuiju theprmt5wdr77complexrestrictshepatitisevirusreplication
AT yanyingyu theprmt5wdr77complexrestrictshepatitisevirusreplication
AT wenlinren theprmt5wdr77complexrestrictshepatitisevirusreplication
AT lindong theprmt5wdr77complexrestrictshepatitisevirusreplication
AT xianbinmeng theprmt5wdr77complexrestrictshepatitisevirusreplication
AT haitengdeng theprmt5wdr77complexrestrictshepatitisevirusreplication
AT yuchennan theprmt5wdr77complexrestrictshepatitisevirusreplication
AT qiangding theprmt5wdr77complexrestrictshepatitisevirusreplication
AT xiaohuiju prmt5wdr77complexrestrictshepatitisevirusreplication
AT yanyingyu prmt5wdr77complexrestrictshepatitisevirusreplication
AT wenlinren prmt5wdr77complexrestrictshepatitisevirusreplication
AT lindong prmt5wdr77complexrestrictshepatitisevirusreplication
AT xianbinmeng prmt5wdr77complexrestrictshepatitisevirusreplication
AT haitengdeng prmt5wdr77complexrestrictshepatitisevirusreplication
AT yuchennan prmt5wdr77complexrestrictshepatitisevirusreplication
AT qiangding prmt5wdr77complexrestrictshepatitisevirusreplication